What's your take on this weeks trading.... Lett
Post# of 5066
Posted On: 12/01/2013 7:36:55 PM
Re: patientgal #3923
What's your take on this weeks trading....
HEADLINE : Letter Perfect_Sierra Called It Correctly As Confirmation Of Pfizer (PFE) And Bio-Matrix Scientific Group (BMSN) Clinical Trial Partnership Forthcoming Following FDA Q&A Concludes Sierra World Equity Review.
Confirmation Of Pfizer (PFE) And Bio-Matrix Scientific Group (BMSN) Clinical Trial Partnership Forthcoming
December will be a monumental month for Bio-Matrix Scientific Group, Sierra's leads now point to two massive official PR's being released detailing the FDA approval of clinical trials to begin for HemaXellerate, followed by a the announcement that Pfizer has entered into a partnership with Bio-Matrix Scientific Group. Sierra anticipates that the share price of Bio-Matrix Scientific Group to start moving up sharply as news leaks with big money coming into the stock. Sierra and her team are monitoring any potential meeting activity at Pfizer HQ in New York City this weekend and will be providing instant updates as needed. Sierra will also be holding a live Skype conference call on Sunday afternoon with her team who are tracking the Pfizer- Ariad Pharmaceuticals potential buyout and discussing the Bio-Matrix Scientific Group-Pfizer budding partnership. For those interested in joining the Skype conference call the time and contact connection details will be published on Sierra's site Sunday afternoon.
Letter Perfect_Sierra Called It Correctly As Confirmation Of Pfizer (PFE) And Bio-Matrix Scientific Group (BMSN) Clinical Trial Partnership Forthcoming Following FDA Q&A Concludes Sierra World Equity Review
HEADLINE : Letter Perfect_Sierra Called It Correctly As Confirmation Of Pfizer (PFE) And Bio-Matrix Scientific Group (BMSN) Clinical Trial Partnership Forthcoming Following FDA Q&A Concludes Sierra World Equity Review.
Confirmation Of Pfizer (PFE) And Bio-Matrix Scientific Group (BMSN) Clinical Trial Partnership Forthcoming
December will be a monumental month for Bio-Matrix Scientific Group, Sierra's leads now point to two massive official PR's being released detailing the FDA approval of clinical trials to begin for HemaXellerate, followed by a the announcement that Pfizer has entered into a partnership with Bio-Matrix Scientific Group. Sierra anticipates that the share price of Bio-Matrix Scientific Group to start moving up sharply as news leaks with big money coming into the stock. Sierra and her team are monitoring any potential meeting activity at Pfizer HQ in New York City this weekend and will be providing instant updates as needed. Sierra will also be holding a live Skype conference call on Sunday afternoon with her team who are tracking the Pfizer- Ariad Pharmaceuticals potential buyout and discussing the Bio-Matrix Scientific Group-Pfizer budding partnership. For those interested in joining the Skype conference call the time and contact connection details will be published on Sierra's site Sunday afternoon.
(0)
(0)